Mineralys Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $28.10 |
Previous Close | $27.59 |
Day Range | $27.05-$28.10 |
52W Range | $12.59-$47.65 |
Market Cap | $2.5B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.97 |
News
See moreYahoo Finance • 30 days ago
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
Yahoo Finance • last month
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Yahoo Finance • last month
Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy
About
CEO | Dr. Jon Congleton |
CFO | Mr. Adam Scott Levy |
Address | 150 N. Radnor Chester Road, Radnor, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |